Approaches for the development of solid and semi-solid lipid-based formulations

被引:273
作者
Jannin, V. [1 ]
Musakhanian, J. [2 ]
Marchaud, D. [1 ]
机构
[1] Gattefosse SAS, F-69804 Saint Priest, France
[2] Gattefosse Corp, Paramus, NJ 07652 USA
关键词
bioavailability enhancement; excipient; formulation; lipid-based drug delivery systems; process; technology;
D O I
10.1016/j.addr.2007.09.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Interest in Lipid Based Drug Delivery (LBDD) has developed over the past decade fuelled by a better understanding of the multiple roles lipids may play in enhancing oral bioavailability. Moreover, the emergence of novel excipients with acceptable regulatory and safety profiles coupled with advances in formulation technologies have greatly improved the potential for successful lipid based formulations. With the growing interest in this field, there is an increasing need for guidelines in excipient selection and characterization; material handling, formulation design, and processing techniques to obtain effective and patient-compliant dosage forms. The aim of this review is to present the recent approaches in selecting the most appropriate lipid system(s); methods for characterization of their behavior in vitro and in vivo; and the current formulation and processing techniques to obtain various solid dosage forms. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:734 / 746
页数:13
相关论文
共 130 条
[101]   Solid dispersion of carbamazepine in PVPK30 by conventional solvent evaporation and supercritical methods [J].
Sethia, S ;
Squillante, E .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 272 (1-2) :1-10
[102]   Physicochemical characterization of solid dispersions of carbamazepine formulated by supercritical carbon dioxide and conventional solvent evaporation method [J].
Sethia, S ;
Squillante, E .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (09) :1948-1957
[103]   Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells [J].
Sha, XY ;
Yan, GJ ;
Wu, YJ ;
Li, JC ;
Fang, X .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 24 (05) :477-486
[104]   Preparation, characterization and in vivo studies of proliposomes containing cyclosporine A [J].
Shah, Neha M. ;
Parikh, Jolly ;
Namdeo, Alok ;
Subramanian, N. ;
Bhowmick, Subhash .
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2006, 6 (9-10) :2967-2973
[105]   Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin [J].
Shen, HaiRong ;
Zhong, MingKang .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2006, 58 (09) :1183-1191
[106]   Application of pressure-controlled colon delivery capsule to oral administration of glycyrrhizin in dogs [J].
Shibata, N ;
Ohno, T ;
Shimokawa, T ;
Hu, ZP ;
Yoshikawa, Y ;
Koga, K ;
Murakami, M ;
Takada, K .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (04) :441-447
[107]   Stabilization and improved in vivo performance of amorphous etoricoxib using Gelucire 50/13 [J].
Shimpi, SL ;
Chauhan, B ;
Mahadik, KR ;
Paradkar, A .
PHARMACEUTICAL RESEARCH, 2005, 22 (10) :1727-1734
[108]   Application of hot-melt coating for controlled release of propranolol hydrochloride pellets [J].
Sinchaipanid, N ;
Junyaprasert, V ;
Mitrevej, A .
POWDER TECHNOLOGY, 2004, 141 (03) :203-209
[109]  
Singh B.N., 2002, ENCY PHARM TECHNOLOG, P886
[110]   Glucocorticoid entrapment into lipid carriers -: characterisation by parelectric spectroscopy and influence on dermal uptake [J].
Sivaramakrishnan, R ;
Nakamura, C ;
Mehnert, W ;
Korting, HC ;
Kramer, KD ;
Schäfer-Korting, M .
JOURNAL OF CONTROLLED RELEASE, 2004, 97 (03) :493-502